iShares Biotechnology ETF (IBB)

171.40
Delayed Data
As of 4:17pm ET
 -0.08 / -0.05%
Today’s Change
128.23
Today|||52-Week Range
177.37
+13.14%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

US Stocks End Mostly Lower Thursday
Sep 16 / GuruFocus News - Paid Partner Content
Moderna ETFs to Rally on Two-in-One Vaccine Booster Shot News
Sep 12 / Zacks.com - Paid Partner Content
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?
Sep 15 / Zacks.com - Paid Partner Content
 

Performance

1 month+2.60% 3 years+13.27%
3 months+6.95% 5 years+11.81%
1 year+29.30% Since inception+8.43%
Data through 09/22/2021

Quote Details

Previous close$171.48
Open day’s range171.16 – 172.62
Net asset value (NAV)171.47 (09/21/2021)
Daily volume94,985
Average volume (3 months)2,863,318
Data as of 4:17pm ET, 09/22/2021

Peer Comparisonvs. Health ETFs

 IBBCategory
Performance 5-yr return+11.81%+15.71%
Expense Gross exp ratio0.45%1.01%
Risk 5 year sharpe ratio0.650.83
Net assets$11.3B$2.6B
Average market cap$24.9B$39.0B
Average P/E26.327.2
Dividend / Share--0.29%

Competitors

IEHS iShares Evolved U.S. Healthcare Staples ...
RYH Invesco S&P 500® Equal Weight Health Ca...
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
MRNA Moderna Inc9.28%
AMGN Amgen6.93%
GILD Gilead Sciences6.57%
REGN Regeneron Pharmaceuticals4.90%
ILMN Illumina Inc4.79%
BNTX BioNTech SE4.19%
VRTX Vertex Pharmaceuticals Inc3.73%
BIIB Biogen3.67%
IQV IQVIA Holdings Inc3.55%
MTD Mettler-Toledo International Inc2.56%